# Evaluation of a Point-of-care Lateral Flow Assay in Glial Fibrillary Acidic Protein (GFAP) and D-dimer in Diagnosis of Large Vessel Occlusion Acute Ischemic Stroke in a Pediatric Hospital

> **NCT07474675** · — · NOT_YET_RECRUITING · sponsor: **Boston Children's Hospital** · enrollment: 250 (estimated)

## Conditions studied

- Stroke Code
- Large Vessel Occlusion
- Acute Ischemic Stroke

## Interventions

- **DEVICE:** Point of Care Rapid Assay

## Key facts

- **NCT ID:** NCT07474675
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2028-01
- **Final completion:** 2028-07
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07474675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07474675, "Evaluation of a Point-of-care Lateral Flow Assay in Glial Fibrillary Acidic Protein (GFAP) and D-dimer in Diagnosis of Large Vessel Occlusion Acute Ischemic Stroke in a Pediatric Hospital". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07474675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*